Skip to content

Clinical reserch on graded diagnosis and treatment for Acute Retinal Necrosis based on fundus performance

Clinical reserch on graded diagnosis and treatment for Acute Retinal Necrosis based on fundus performance

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106445
Enrollment
Unknown
Registered
2025-07-23
Start date
2025-07-24
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Retinal Necrosis

Interventions

Medical Treatment Group :intravitreal and systemic antiviral drug therapy
prophylactic vitrectomy group:undergoing elective vitretomy, besides intravitreal and systemic antiviral drug therapy
vitretomy group :undergoing emergency vitretomy, besides intravitreal and systemic antiviral drug therapy

Sponsors

The First Affiliated Hospital of USTC
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1)The patients underwent examinations, including slit lamp microscope, indirect ophthalmoscope, ocular B-ultrasound and intraocular fluid detection, and was diagnosed as acute retinal necrosis, according to Classification Criteria for Acute Retinal Necrosis Syndrome published by Standardization of Uveitis Nomenclature (SUN) Working Group in 2021. 2) Good compliance, able to cooperate and complete relevant examinations and treatments.

Exclusion criteria

Exclusion criteria: 1)History of ocular surgery or trauma, including cataract surgery within 6 months; 2) With other systemic diseases, unable to cooperate and tolerate examination and treatment; 3) No intraocular fluid test or two intraocular fluid PCR tests were negative; 4) Failed to complete antiviral and related treatment;5)Patients whose affected eye meets the criteria for vitrectomy but refuse to undergo the surgical procedure.

Design outcomes

Primary

MeasureTime frame
Best-corrected visual acuity (BCVA) ;Retinal reattachment status;

Secondary

MeasureTime frame
viral load of intraocular fluid;

Countries

China

Contacts

Public ContactGu Yonghao

The First Affiliated Hospital of University of Science and Technology of China

guyh@ustc.edu.cn+86 137 2102 5725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026